- Medical devices
- Pharmaceuticals/life sciences
- Website: http://www.ipgroupplc.com
Head, IP at IP Group plc
After his undergraduate degree and PhD in chemistry at Cambridge University, Jeremy Holmes spent two years at the Louis Pasteur University in Strasbourg working with Nobel laureate Professor Jean-Marie Lehn.
Dr Holmes then joined ICI Organics Division in Manchester and worked in their R&D function in a variety of roles, including three years in the Netherlands, followed by a Royal Society Industrial Fellowship at Edinburgh University.
In 2000 Dr Holmes entered the IP profession at ICI and qualified as a UK and European patent attorney. He was responsible for the management of patent portfolios in technologies in dyestuffs and polymer coatings.
In 2004 Dr Holmes joined leading fast-moving consumer goods company Reckitt Benckiser, where he managed global patent and design portfolios for key brands such as Airwick, Veet, Clearasil, Mortein and Harpic, and gained extensive experience in IP litigation and due diligence.
In January 2012 Dr Holmes joined Imperial Innovations (then the technology transfer partner for Imperial College) as IP due diligence manager. He built the in-house IP skills in the tech transfer team to manage its considerable IP portfolio (more than 400 patent families), interacted with external service providers and built in-house patent searching skills. For Innovations’ investment arm, Touchstone Innovations, he ensured that thorough and timely due diligence was carried out on investment opportunities, and reviewed in detail the IP assets of potential investments. Dr Holmes also acted as an in-house consultant on IP issues and provided IP education at Imperial College.
Following the merger of Touchstone and Imperial Innovations into IP Group plc in 2017, and Imperial College’s decision to take its tech transfer function back in-house in March 2019, Dr Holmes remained at IP Group, as head of intellectual property, where he provides a wide range of in-house IP services for the company and its portfolio companies, which are based in the United Kingdom, Australia and the United States.